Outlook Therapeutics Inc (OTLK) Price Prediction & ForecastOTLKOutlook Therapeutics Inc

Alphio's OTLK stock price prediction model matches the current Outlook Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.44 (-0.48%). The 1-week path is $0.41 (-5.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Outlook Therapeutics Inc (OTLK) is currently trading at $0.4692, significantly below its 52-week high of $2.54, indicating a potential for recovery. However, the stock has a low RSI of 31.097, suggesting it is oversold but also reflects ongoing bearish sentiment. The company has reported a net loss of $20.3 million in Q3 2026, and its gross margin has plummeted to -95% in the same quarter, which raises concerns about financial stability. Despite the positive catalyst of FDA approval for LYTENAVA, the current financial performance and high volatility suggest caution. The main risk is the ongoing losses, with a net margin of -233554.85%.

Outlook Therapeutics Inc (OTLK) last closed at $0.4391, losing -4.98%. These facts feed the 1-day and 1-week OTLK price prediction above.